Global Pharmaceuticals & Biotech Healthy potentially undervalued

High Tide

Market Cap: CA$278.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

TG Therapeutics

Market Cap: US$6.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Innovent Biologics

Market Cap: HK$157.2b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

Kissei Pharmaceutical

Market Cap: JP¥161.9b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Arcutis Biotherapeutics

Market Cap: US$3.3b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

CorMedix

Market Cap: US$590.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

United Therapeutics

Market Cap: US$22.2b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Hypera

Market Cap: R$15.2b

Operates as a pharmaceutical company in Brazil.

Yunnan Baiyao GroupLtd

Market Cap: CN¥90.8b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

Hugel

Market Cap: ₩2.8t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

UCB

Market Cap: €43.7b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Kuros Biosciences

Market Cap: CHF 928.3m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Supernus Pharmaceuticals

Market Cap: US$2.5b

A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.

Dong-E-E-Jiao

Market Cap: CN¥34.6b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Shionogi

Market Cap: JP¥2.3t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Bavarian Nordic

Market Cap: DKK 13.7b

Develops, manufactures, and supplies life-saving vaccines.

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €193.8m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

Ardelyx

Market Cap: US$1.2b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Prestige Consumer Healthcare

Market Cap: US$2.5b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

Diaceutics

Market Cap: UK£122.8m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Dong-A ST

Market Cap: ₩358.6b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

Amoy Diagnostics

Market Cap: CN¥6.8b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

Journey Medical

Market Cap: US$176.2m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Decibel Cannabis

Market Cap: CA$63.5m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

Fennec Pharmaceuticals

Market Cap: US$351.2m

Operates as a commercial stage biopharmaceutical company in the United States.

United Laboratories International Holdings

Market Cap: HK$18.0b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Daewoong Pharmaceutical

Market Cap: ₩1.4t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$30.4b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

Perrigo

Market Cap: US$1.5b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$470.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Otsuka Holdings

Market Cap: JP¥6.2t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

Tasly Pharmaceutical Group

Market Cap: CN¥23.5b

Engages in the research, development, production, and sale of pharmaceuticals in China.

Takeda Pharmaceutical

Market Cap: JP¥8.4t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.